摘要
87例瘤栓位于门脉主干或一级分支的肝癌病人,经肝动脉化疗或栓塞后,半年、1年生存率各为41.38％、12.64％;其中12例瘤栓明显缩小,3例瘤栓消失。认为栓塞疗法优于单纯灌注法。文中还对门脉瘤栓的血供,治疗方法的选择和禁忌证等作了探讨。
87 cases of hepatoma accompanied by tumor thrombus in the trunk or the first order branch of the portal vein were treated by hepatic artery infu-sior (HAI) or embolization (HAE). The over 6-month survival rate was 41.38% and the one-year survival rate 12.64%. The tumor thrombus decreased significantly in size in 12 cases or disappeared in 3 cases. The blood supply of the portal vein tumor thrombus, selection of therapeutic methods and contraindications were discussed.
出处
《同济医科大学学报》
CAS
CSCD
北大核心
1992年第4期227-229,F003,共4页
Acta Universitatis Medicinae Tongji
关键词
门脉瘤栓
栓塞
化学疗法
肝肿瘤
portal vein, portal tumor thrombus
hepatoma
embolization, transhepatk
chemotherapy
